The Government Urged to Erase Social Media Claims About the Vaccine Program Denunciation

Unexpectedly, The Thai court directed a leading government enemy to delete social media claims that the coronavirus vaccine program of the state is vague and disproportionately benefits a king-owned company. Nevertheless, the Democratic Campaign of opposition politician Thanathorn Juangroongruangkit denied the videos were illegal and urged YouTube and Facebook to protect democracy.

The Criminal Court ruled that Mr Thanathorn’s posts on social media and his movement’s website might violate national security. The videos accuse the government of Prime Minister Prayut Chan-o-cha of avoiding accountability in enabling, despite a lack of vaccine expertise, Siam Bioscience, which is owned by King Maha Vajiralongkorn, to supply most doses.

In a 2019 referendum to retain power a claim he rejects opponents argue former junta leader Prayuth rigged a vote and violated a national silence by increasingly criticising the monarchy. A 600 million baht (S$13.4 million) subsidy was obtained by Siam Bioscience to build the capacity to produce AstraZeneca vaccines domestically and throughout Southeast Asia.

When approached by Reuters, the court did not comment. The Campaign of Mr. Thanathorn said it had not earned the ruling. The government has also filed a video complaint against him, accusing him of offending monarchy, an accusation punishable by up to 15 years in jail.

The government says the development of Siam Bioscience is on schedule to provide to the public a first batch of 61 million doses by June. There was no immediate comment on the court decision from Mr Thanathorn or Siam Bioscience. Traditionally, the palace does not elaborate on political conflicts.

Relatively unscathed by Covid-19, Thailand confirmed 829 new cases of coronavirus recently, taking the total since the epidemic began last January to 18,782 cases and 77 fatalities.

Looking back the delivering 50,000 doses of AstraZeneca vaccine to high-risk groups next month, will launch its coronavirus inoculation campaign, as it faces charges of being too late to procure vaccines.

The food and drug administration of Thailand approved the AstraZeneca vaccine for emergency use, but has yet to give authorisation to Sinovac Biotech, of which two million doses have been requested by Thailand. However, Health Minister Anutin Charnvirakul said AstraZeneca will provide 50,000 fewer doses of the vaccine than the 200,000 requested by Thailand. Through this, it’s a mystery to think about the things happening in inoculation of the vaccine throughout the nation.

Burapha

Sawadee-khrup. I am a multicultural Thai newswriter that is always on the lookout for daily news that are intriguing and unique in my native country Thailand.

Recent Posts

Malaysia Job Market 2025–26: High-Demand Jobs, Salaries, and Career Opportunities

The future of Malaysia job market 2025-26 has high opportunities of the skilled professionals who are willing to extend their…

December 13, 2025

Mexico Gives Green Light to Steep Tariffs on Chinese and Foreign Goods

Mexico has accepted a new wave of steep tariffs on Chinese and other foreign goods, which is a big change…

December 13, 2025

Japan’s Growing Dementia Crisis and the High-Tech Race to Protect Its Elderly

Japan has a rapidly growing population with in excess of 28 per cent of its citizens being over the age…

December 13, 2025

Malaysia’s First Large-Scale Battery Storage System Inaugurated in Sabah, Borneo

With this clean-energy move, Malaysia has thus made a historic breakthrough as it is witnessed with the opening of the…

December 12, 2025

Endangered No More? World’s Rarest Ape Faces Extinction After Floods in Sumatra

Sumatra, which has a lot of different kinds of plants and animals and is famous for its beautiful jungles and…

December 12, 2025

Sri Lanka’s Tea Heartland in Ruins After Ditwah’s Fury

Sri Lanka's famous tea-growing area was devastated when Cyclone Ditwah went through the central highlands, destroying farms and forcing thousands…

December 12, 2025

This website uses cookies.

Read More